We are live on ! Find out more
UOC

UBS O'Connor Portfolio holdings

AUM $3.38B
1-Year Est. Return 63.08%
This Fund
S&P 500
This Quarter Est. Return
+13.06%
1 Year Est. Return
+63.08%
3 Year Est. Return
+180.99%
5 Year Est. Return
+483.22%
10 Year Est. Return
+2,128.62%
AUM
$4.23B
AUM Growth
+$208M
Cap. Flow
+$191M
Cap. Flow %
4.51%
Top 10 Hldgs %
66.8%
Holding
503
New
83
Increased
81
Reduced
97
Closed
181

Top Buys

Rank Stock Value
1
ITCI
Intra-Cellular Therapies Inc.
ITCI
+$383M
2
DFS
Discover Financial Services
DFS
+$224M
3
BECN
Beacon Roofing Supply, Inc.
BECN
+$183M
4
WBA
Walgreens Boots Alliance
WBA
+$110M
5
JWN
Nordstrom
JWN
+$95.8M

Top Sells

Rank Stock Value
1
HCP
HashiCorp, Inc. Class A Common Stock
HCP
+$235M
2
SMAR
Smartsheet Inc.
SMAR
+$216M
3
EDR
Endeavor Group Holdings, Inc.
EDR
+$144M
4
SUM
Summit Materials, Inc. Class A Common Stock
SUM
+$103M
5
ALTR
Altair Engineering Inc
ALTR
+$97.9M

Sector Composition

Rank Sector Weight
1 Energy 17.21%
2 Healthcare 16.93%
3 Financials 12.93%
4 Industrials 12.5%
5 Technology 10.61%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ET icon
276
CALL
Energy Transfer Partners
ET
$71.2B
$49.6K ﹤0.01%
+320,000
New +$6.23M
VERU icon
277
Veru
VERU
$37.1M
$49.5K ﹤0.01%
10,102
-22,884
-69% -$142K
MGNI icon
278
CALL
Magnite
MGNI
$3.49B
$48.1K ﹤0.01%
107,000
– –
INO icon
279
Inovio Pharmaceuticals
INO
$69.6M
$47.9K ﹤0.01%
29,375
-195,625
-87% -$393K
FE icon
280
PUT
FirstEnergy
FE
$27.4B
$44.9K ﹤0.01%
26,000
– –
CNTX icon
281
Context Therapeutics
CNTX
$46.3M
$41.4K ﹤0.01%
67,631
-241,127
-78% -$210K
CE icon
282
CALL
Celanese
CE
$4.82B
$40.3K ﹤0.01%
+70,000
New +$4.37M
PEPG icon
283
PepGen
PEPG
$167M
$37.3K ﹤0.01%
+26,559
New +$54.7K
MRSN
284
DELISTED
Mersana Therapeutics
MRSN
$33.6K ﹤0.01%
3,909
-12,492
-76% -$193K
VNO icon
285
PUT
Vornado Realty Trust
VNO
$7.27B
$32.7K ﹤0.01%
33,500
– –
INZY
286
DELISTED
Inozyme Pharma
INZY
$31.7K ﹤0.01%
34,788
-166,444
-83% -$231K
ACRV icon
287
Acrivon Therapeutics
ACRV
$72.3M
$31.6K ﹤0.01%
15,576
-87,208
-85% -$470K
BPMC
288
PUT
DELISTED
Blueprint Medicines
BPMC
$30.8K ﹤0.01%
+10,000
New +$976K
QURE icon
289
CALL
uniQure
QURE
$3.15B
$29.3K ﹤0.01%
65,000
-50,000
-43% -$701K
PRCT icon
290
PUT
Procept Biorobotics
PRCT
$1.15B
$27.4K ﹤0.01%
+15,000
New +$1.02M
OXY icon
291
PUT
Occidental Petroleum
OXY
$56B
$24.6K ﹤0.01%
+90,000
New +$4.39M
CCL icon
292
CALL
Carnival Corporation Ltd
CCL
$39.4B
$24K ﹤0.01%
+150,000
New +$3.57M
KDKRW
293
Kodiak AI Warrants
KDKRW
$23.6K ﹤0.01%
82,711
– –
STRO icon
294
Sutro Biopharma
STRO
$400M
$18.4K ﹤0.01%
2,828
-27,234
-91% -$429K
AKAM icon
295
CALL
Akamai
AKAM
$17.2B
$14.1K ﹤0.01%
+37,500
New +$3.36M
NKTR icon
296
Nektar Therapeutics
NKTR
$2.48B
$13.5K ﹤0.01%
1,328
-104,066
-99% -$1.36M
AENTW icon
297
Alliance Entertainment Holding Corp Warrants
AENTW
$4.27M
$13.4K ﹤0.01%
60,000
-54,255
-47% -$15.6K
XAGEW
298
DELISTED
Longevity Health Holdings, Inc. Warrant
XAGEW
$13.4K ﹤0.01%
371,250
– –
COO icon
299
PUT
Cooper Companies
COO
$14.3B
$9.38K ﹤0.01%
15,000
+3,000
+25% +$269K
TVGNW icon
300
Tevogen Inc. Warrant
TVGNW
$899K
$8.98K ﹤0.01%
181,387
– –
10 11
12
13 14

Similar funds

FNBT
FineMark National Bank & Trust Fort Myers, Florida $3.2B AUM 18.28% 1-Year Est. Return
SAG
SageView Advisory Group Newport Beach, California $2.96B AUM 15.81% 1-Year Est. Return
ACI
Alpha Cubed Investments Irvine, California $2.92B AUM 31.27% 1-Year Est. Return
TCOV
Trust Company of Vermont Brattleboro, Vermont $2.4B AUM 18.8% 1-Year Est. Return
RC
RGM Capital Naples, Florida $2.06B AUM 8.49% 1-Year Est. Return
A
AlphaQuest New York $1.79B AUM 10.61% 1-Year Est. Return
CGL
Clarius Group LLC Seattle, Washington $1.75B AUM 19.04% 1-Year Est. Return
CB
Cadence Bank Tupelo, Mississippi $1.71B AUM 16.17% 1-Year Est. Return

UBS O'Connor's Q1 2025 Portfolio in Review

As of Q1 2025, UBS O'Connor held 503 positions worth $4.23B, up 5.2% from $4.02B the previous quarter. Its ten largest holdings account for 67% of the portfolio.

UBS O'Connor deployed $191M of net new capital in Q1 2025, opening 83 new positions and adding to 81 existing holdings. Its largest new stake was Beacon Roofing Supply, Inc.: 1,575,016 shares worth $195M.

By sector, the portfolio is most concentrated in Energy at 17% of assets, up from 16% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Juniper Networks, an estimated $71.4M trimmed.

  • UBS O'Connor's largest Q1 2025 buy was Beacon Roofing Supply, Inc.: 1,575,016 shares worth $195M.
  • UBS O'Connor added most to Intra-Cellular Therapies Inc. in Q1 2025, an estimated $383M increase.
  • UBS O'Connor's biggest Q1 2025 reduction was Juniper Networks, cutting an estimated $71.4M.
  • UBS O'Connor fully exited HashiCorp, Inc. Class A Common Stock in Q1 2025, selling an estimated $235M.
  • UBS O'Connor's ten largest holdings make up 67% of its $4.23B portfolio in Q1 2025.
  • UBS O'Connor opened 83 new positions and closed 181 in Q1 2025.
  • UBS O'Connor's portfolio value rose 5.2% quarter-over-quarter to $4.23B.

Based on UBS O'Connor's 13F filing for Q1 2025, filed 15 May 2025.